Takeyama Koh, Matsukawa Masanori, Kunishima Yasuharu, Takahashi Satoshi, Hotta Hiroshi, Nishiyama Naotaka, Tsukamoto Taiji
Department of Urology, Sapporo Medical University School of Medicine, Japan.
J Infect Chemother. 2005 Aug;11(4):177-81. doi: 10.1007/s10156-005-0391-1.
In radical cystectomy (RC), surgical-site infection (SSI) remains one of the most frustrating postoperative complications. Only a few reports have assessed SSI after RC according to the guideline authorized by the Centers for Disease Control and Prevention (CDC guideline). In this study, using the guideline, we assessed the incidence, causative organisms, classification, and risk factors for SSI in patients receiving RC with urinary diversion (UD). The subjects of this study were 104 patients who underwent RC with UD at the Department of Urology, Sapporo Medical University Hospital, between January 1996 and December 2003. As prophylactic antimicrobial agents, intravenous cephalosporins or penicillins were started before surgery and maintained until postoperative day 3. Patients who had preoperative bacteriuria were treated with antimicrobial agents before operation to eradicate the bacteria or reduce their number. The CDC guideline was used for the diagnosis of SSI. The overall incidence of SSI was 33%. The most frequent type of SSI was superficial incisional infection (71%). Methicillin-resistant Staphylococcus aureus (MRSA) was the most frequently isolated organism, accounting for 38% of the causative organisms. Operation time was shown to be a significant risk factor for SSI. Preoperative antibacterial chemotherapy for bacteriuria was not sufficiently efficacious to decrease the incidence of SSI. In our study, the incidence of SSI after RC was 33%, although 71% of the infections were superficial. It is necessary to establish more appropriate countermeasures to prevent SSI after RC with UD; in particular, that caused by MRSA.
在根治性膀胱切除术(RC)中,手术部位感染(SSI)仍然是最令人沮丧的术后并发症之一。只有少数报告根据美国疾病控制与预防中心授权的指南(CDC指南)评估了RC后的SSI。在本研究中,我们使用该指南评估了接受尿流改道术(UD)的RC患者中SSI的发生率、致病微生物、分类及危险因素。本研究的对象为1996年1月至2003年12月期间在札幌医科大学医院泌尿外科接受UD的RC患者104例。作为预防性抗菌药物,术前开始静脉输注头孢菌素或青霉素,并持续至术后第3天。术前有菌尿的患者在手术前接受抗菌药物治疗以根除细菌或减少其数量。SSI的诊断采用CDC指南。SSI的总体发生率为33%。最常见的SSI类型为表浅切口感染(71%)。耐甲氧西林金黄色葡萄球菌(MRSA)是最常分离出的微生物,占致病微生物的38%。手术时间被证明是SSI的一个重要危险因素。术前针对菌尿的抗菌化疗不足以降低SSI的发生率。在我们的研究中,RC后SSI的发生率为33%,尽管71%的感染为表浅感染。有必要制定更合适的对策来预防UD的RC术后的SSI;尤其是由MRSA引起的SSI。